Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Pascal, Turlure"'
Autor:
Claire Lacan, Jérôme Lambert, Edouard Forcade, Marie Robin, Patrice Chevallier, Sandrine Loron, Claude-Éric Bulabois, Corentin Orvain, Patrice Ceballos, Etienne Daguindau, Amandine Charbonnier, Yves Chalandon, Marc Bernard, Célestine Simand, Marie-Thérèse Rubio, Pascal Turlure, Johan Maertens, Anne Huynh, Michael Loschi, Jacques-Olivier Bay, Gaëlle Guillerm, Mustafa Alani, Cristina Castilla-Llorente, Xavier Poiré, Sylvain Chantepie, Natacha Maillard, Yves Beguin, Ambroise Marçais, Jérôme Cornillon, Jean-Valère Malfuson, Sébastien Maury, Nathalie Meuleman, Alban Villate, Mohammed-Amine Bekadja, Anouk Walter-Petrich, Nathalie Jacque, Micha Srour, Raynier Devillier, Stéphanie Nguyen
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract The use of peripheral blood (PB) or bone marrow (BM) stem cells graft in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis remains controversi
Externí odkaz:
https://doaj.org/article/06528184135d4dc9a33935cb6d4ee598
Autor:
Eleonore Kaphan, Francois Bettega, Nicolas Vallet, Nathalie Fegueux, Marie Robin, Ali Bazarbachi, Stephanie Nguyen, David Beauvais, Edouard Forcade, Maria Carolina Montes De Oca, Raynier Devillier, Patrice Chevallier, Michael Loschi, Anne Huynh, Jacques-Olivier Bay, Marie-Therese Rubio, Felipe Suarez, Sylvie Francois, Xavier Poire, Nathalie Contentin, Deborah Desmier, Amandine Charbonnier, Jerome Cornillon, Sylvain Chantepie, Pascal Turlure, Claude-Eric Bulabois, David Michonneau, Alban Villate, SFGM-TC
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/0442c31537014ecdb767e249bc1317ae
Autor:
Maxime Roubinet, David Rizzo, Jasmine Chauzeix, Pascal Turlure, Marie-Pierre Laforet, Paco Derouault, Jean Feuillard, Catherine Yardin, Marie-Mathilde Auboiroux, Léa Veyrune, Alexandre Perani, Sylvie Bourthoumieu, Benjamin Dauriat, Nathalie Gachard
Publikováno v:
HemaSphere, Vol 7, p e173837c (2023)
Externí odkaz:
https://doaj.org/article/ab20469eedcf4af7a3aa8b0a18b13828
Autor:
Alexandre Perani, Sylvie Bourthoumieu, David Rizzo, Jasmine Chauzeix, Benjamin Dauriat, Pascal Turlure, Stéphane Girault, Léa Veyrune, Maxime Roubinet, Jean Feuillard, Catherine Yardin, Nathalie Gachard
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPredisposition to myeloid malignancies is a field at the border of hematology and genetics. Knowledge in this domain has so rapidly increased that WHO defined in 2016 the new “Myeloid Neoplasms with Germline Predisposition” category of
Externí odkaz:
https://doaj.org/article/2983c16b234649e8be5f75d4c94ad043
Autor:
Stéphanie Dulucq, Franck E. Nicolini, Delphine Rea, Pascale Cony-Makhoul, Aude Charbonnier, Martine Escoffre-Barbe, Valérie Coiteux, Pascal Lenain, Françoise Rigal-Huguet, Jixing Liu, Agnès Guerci-Bresler, Laurence Legros, Jean-Christophe Ianotto, Martine Gardembas, Pascal Turlure, Viviane Dubruille, Philippe Rousselot, Juliana Martiniuc, Henry Jardel, Hyacinthe Johnson-Ansah, Bertrand Joly, Tawfiq Henni, Emilie Cayssials, Patricia Zunic, Marc G. Berger, Bruno Villemagne, Fanny Robbesyn, Stephane Morisset, François-Xavier Mahon, Gabriel Etienne
Publikováno v:
Haematologica, Vol 107, Iss 12 (2022)
Discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia is feasible in clinical practice based on recently published international recommendations. Nevertheless, factors predictive of molecular recurrence have not been
Externí odkaz:
https://doaj.org/article/28263e36eb3a4f589724f3b48b82115e
Autor:
Imran Ahmad, Laetitia Souchet, Fati Hamzy, Patrice Ceballos, Yohann Desbrosses, Aurélie Ravinet, Pascal Turlure, Alban Villate, Cécile Borel, Hanane Benbarkat, Ibrahim Yakoub-Agha, Thierry Guillaume
Publikováno v:
Bulletin du Cancer. 110:S56-S66
Autor:
Micha Srour, Tamim Alsuliman, Julien Labreuche, Claude-Eric Bulabois, Patrice Chevallier, Etienne Daguindau, Edouard Forcade, Sylvie François, Gaelle Guillerm, Valerie Coiteux, Pascal Turlure, Yves Beguin, Ibrahim Yakoub-Agha, Leonardo Magro
Publikováno v:
Bone Marrow Transplantation. 58:401-406
Autor:
Auriane Lesieur, Xavier Thomas, Olivier Nibourel, Nicolas Boissel, Laurène Fenwarth, Stéphane De Botton, Elise Fournier, Karine Celli-Lebras, Emmanuel Raffoux, Christian Recher, Juliette Lambert, Céline Berthon, Arnaud Pigneux, Raphael Itzykson, Pascal Turlure, Cécile Pautas, Jacques Vargaftig, Claude Preudhomme, Hervé Dombret, Nicolas Duployez
Publikováno v:
Haematologica, Vol 106, Iss 6 (2020)
Externí odkaz:
https://doaj.org/article/b7940712ba5c4bc583ef5d93f55d35d1
Autor:
Olaf Penack, Christophe Peczynski, Steffie van der Werf, Jürgen Finke, Arnold Ganser, Helene Schoemans, Jiri Pavlu, Riitta Niittyvuopio, Wilfried Schroyens, Leylagül Kaynar, Igor W. Blau, Walter van der Velden, Jorge Sierra, Agostino Cortelezzi, Gerald Wulf, Pascal Turlure, Montserat Rovira, Zubeydenur Ozkurt, Maria J. Pascual-Cascon, Maria C. Moreira, Johannes Clausen, Hildegard Greinix, Rafael F. Duarte, Grzegorz W. Basak
Publikováno v:
Haematologica, Vol 105, Iss 7 (2020)
Uric acid is a danger signal contributing to inflammation. Its relevance to allogeneic stem cell transplantation (alloSCT) derives from preclinical models where the depletion of uric acid led to improved survival and reduced graft-versus-host disease
Externí odkaz:
https://doaj.org/article/014b3334707f4920ab63efcacd76b81a
Autor:
Olivier Tournilhac, Magali Le Garff-Tavernier, Stéphanie Nguyen Quoc, Edouard Forcade, Patrice Chevallier, Faezeh Legrand-Izadifar, Gandhi Laurent Damaj, David Michonneau, Cécile Tomowiak, Cécile Borel, Corentin Orvain, Pascal Turlure, Rabah Redjou, Gaëlle Guillerm, Laure Vincent, Celestine Simand, Richard Lemal, Claire Quiney, Patricia Combes, Bruno Pereira, Laure Calvet, Aurélie Cabrespine, Jacques-Olivier Bay, Véronique Leblond, Nathalie Dhédin, French Innovative Leukemia Organization (FILO), Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Publikováno v:
Haematologica, Vol 106, Iss 7 (2020)
Allogeneic hematopoietic stem cell transplantation (HSCT) remains a potentially curative and useful strategy in high-risk relapsing CLL. Minimal Residual Disease (MRD) assessment at 12 months post-HSCT is predictive of relapse. This phase 2 study aim
Externí odkaz:
https://doaj.org/article/513b282ddfd94a8f8cbad1c4cbd28f6d